Catalyst

Slingshot members are tracking this event:

Phase 2 data of MM-121 for Heregulin Positive Non-Small Cell Lung Cancer due 2H 2018

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
MACK

100%

Additional Information

Additional Relevant Details Update on March 12 2018: Initially expected in 2018, timeline got narrowed down to 2H 2018
http://investors.mer...
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 2 Data, Mm-121, Heregulin Positive Non-small Cell Lung Cancer